Paul K.S. Chan
The Chinese University of Hong Kong
669 Papers
4.3K Citations
Paul K.S. Chan is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 87, co-authored 602 publications. Previous affiliations of Paul K.S. Chan include Queen Mary University of London & University of Louisville.
Chat about Author
Papers
In silico prediction of influenza vaccine effectiveness by sequence analysis.
Lirong Cao,Jingzhi Lou,Shi Zhao,Renee W. Y. Chan,Martin C.W. Chan,William K.K. Wu,Marc K. C. Chong,Benny Zee,Eng-Kiong Yeoh,Samuel Y. S. Wong,Paul K.S. Chan,Maggie Haitian Wang +11 more
TL;DR: Based on the genetic distance of hemagglutinin and neuraminidase gene of the influenza viruses to vaccine strains, statistically quantified the relationship between the genetic mismatch and vaccine effectiveness as mentioned in this paper.
13
Impact of neonatal hepatitis B vaccination programme on age-specific prevalence of hepatitis B infection in teenage mothers in Hong Kong.
TL;DR: Regression analysis indicated there was a significantly higher incidence of HBsAg carriage from age 17 onwards, suggesting that the protective effect of the vaccine declined in late adolescence.
Short-Term Safety and Efficacy of Low-Dose Simvastatin in Elderly Patients with Hypertensive Hypercholesterolemia and Fasting Hyperinsulinemia
TL;DR: Results of this study confirmed that a low dose (10 mg) of simvastatin daily is a safe and effective method of reducing plasma levels of total and low‐density lipoprotein cholesterol in hypercholesterolemic, hypertensive elderly patients receiving concurrent antihypertensive drug therapy, and that it has the additional potential benefit of reducing Plasma levels of insulin.
13
The effect of intragastric balloon placement on weight loss and type 2 diabetes control.
Aoo Chan,Wing Sun Chow,Kwok Fai Lam,A. Hsu,Ivan Hung,Paul K.S. Chan,D. But,Wai-Kay Seto,K. S. L. Lam +8 more
TL;DR: It is postulated that, by reducing weight and diet intake via placement of intragastric balloon, diabetic control could be improved in the obese patients with poorly controlled type 2 diabetes.
13